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Abstract
It is generally recognized that the function of the immune system declines with
increased age and one of the major immune changes is impaired T‐cell responses
upon antigen presentation/stimulation. Some “high‐performing” centenarians (100+
years old) are remarkably successful in escaping, or largely postponing, major age‐re-
lated diseases. However, the majority of centenarians (“low‐performing”) have expe-
rienced these pathologies and are forced to reside in long‐term nursing facilities.
Previous studies have pooled all centenarians examining heterogeneous populations
of resting/unstimulated peripheral blood mononuclear cells (PBMCs). T cells repre-
sent around 60% of PBMC and are in a quiescence state when unstimulated. How-
ever, upon stimulation, T cells rapidly divide and exhibit dramatic changes in gene
expression. We have compared stimulated T‐cell responses and identified a set of
transcripts expressed in vitro that are dramatically different in high‐ vs. low‐perform-
ing centenarians. We have also identified several other measurements that are dif-
ferent between high‐ and low‐performing centenarians: (a) The amount of
proliferation following in vitro stimulation is dramatically greater in high‐performing
centenarians compared to 67‐ to 83‐year‐old controls and low‐performing centenari-
ans; (b) telomere length is greater in the high‐performing centenarians; and (c)
telomerase activity following stimulation is greater in the high‐performing centenari-
ans. In addition, we have validated a number of genes whose expression is directly
related to telomere length and these are potential fundamental biomarkers of aging
that may influence the risk and progression of multiple aging conditions.
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1 | INTRODUCTION
There have been longitudinal human studies demonstrating specific
changes in immune responses that correlate with many causes of
increased morbidity and mortality with increased age (Wikby et al.,
2006). For example, it is already known that many older individuals
(>65 years old) have impaired responses to pathogens such as influ-
enza virus (Murphy, Xu, & Kochanek, 2013). Thus, it is important to
better understand the underlying biological mechanisms that con-
tribute to age‐related impairment of immune functions in order to
develop appropriate preventative and therapeutic strategies to meet
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the medical and health demands of an increasing elderly population
worldwide.
Some centenarians (individuals who are at least 100 years old)
reach what is currently the extreme limit of human life by escaping,
or largely postponing, the major age‐related diseases and retaining
physical independence for an extraordinary long period. For these
reasons, they can be considered a paradigm for the study of healthy
aging. Previous studies of long‐lived families have been carried out
from several perspectives, such as genetics (Beekman et al., 2013),
epigenetics (Gentilini et al., 2013), and transcriptomics (Passtoors
et al., 2012), leading to the identification of characteristic profiles of
both longevity and healthy aging. However, these investigations
have focused on the behavior of resting immune cells (e.g., periph-
eral blood mononuclear cells, PBMCs). Peripheral blood mononuclear
cells are a heterogeneous cell population mainly consisting of T cells,
a major component of human immune responses. T cells remain in a
resting or quiescent state when unstimulated, showing little or no
proliferation activity. In contrast, upon antigen‐specific activation, T
cells rapidly divide and exhibit dramatic changes in gene expression
(over 7,000 genes are differentially expressed in resting vs. stimu-
lated T cells) (Zhao, Fung‐Leung, Bittner, Ngo, & Liu, 2014).
Activated T cells initiate immune responses such as discriminating
between healthy and abnormal (e.g., infected or cancerous) cells in the
body and thus represent a model to study the physiological function
of the adaptive immune system (including inflammatory signaling).
Comparing stimulated T‐cell responses in different age groups includ-
ing centenarians is an understudied area of research and might thus
provide new insights about the mechanisms driving the age‐related
impairment of the immune system as well as the mechanisms responsi-
ble for at least a subset of centenarians’ extremely healthy aging.
With the goal of identifying genes and pathways potentially
involved in the process of healthy aging and longevity, this series of
pilot studies involving 114 individuals was designed to characterize
and compare the stimulation‐induced responses in T cells from 19
young (23–39 years old), 48 middle‐aged (50–66 years old), 26 old
(67–83 years old), and 21 very old (centenarians: 100+ years old)
individuals. We used whole genome RNA‐sequencing, telomerase
activity, and telomere length assays to compare the function of stim-
ulated T cells from a subset of the study groups listed above. Based
on these preliminary investigations, we are now able to separate
low‐performing from high‐performing centenarians and potentially
disentangle age‐associated pathology from a set of promising under-
lying biochemical biomarkers of healthy aging.
2 | RESULTS
2.1 | Stimulated T cells from centenarians show
robust telomerase activity and replicative potential
Telomeres are tandem repeats that cap the end of linear chromo-
somes to protect them from degradation and to prevent chromo-
some fusions (Shay, 2016). In normal human proliferating cells,
telomeres get progressively shorter with each cell division, leading
eventually to DNA damage responses, replicative senescence, or
apoptosis (Shay, 2016). One consequence of proliferation is that
telomere length declines with age and is considered a marker of bio-
logical (not chronological) age (Epel et al., 2009) that correlates with
various age‐related pathologies including cancer (Shay, 2016),
dementia (Tedone et al., 2015), and cardiovascular diseases (Epel
et al., 2009). However, some cell types such as proliferating stem‐
like cells and antigen‐stimulated T cells express regulated telomerase
activity, a ribonucleoprotein enzyme complex whose specialized
reverse transcriptase action performs de novo addition of telomeric
TTAGGG repeats at the end of telomeres, thus slowing down the
rate of telomere attrition that occurs during cell division (Shay,
2016).
Our previous study on unstimulated leukocytes isolated from
peripheral blood showed that a subset of centenarians underwent a
slower rate of telomere shortening compared with the normal popula-
tion (Tedone et al., 2014). We hypothesized that in some centenarians,
T cells have increased telomerase activity leading, in turn, to better
telomere length maintenance mechanisms. In the present studies, we
employed a droplet digital PCR assay (the ddTRAP assay) (Ludlow et al.,
2014) to measure telomerase activity. This assay provides an absolute
quantification of telomerase activity even at the single cell level.
Unstimulated T cells (day 0) showed extremely low telomerase activity,
and no significant differences were found between the study groups
(Figure 1a). Consistent with a previous study (Huang et al., 2017), upon
T‐cell stimulation, telomerase activity was transiently up‐regulated,
generally peaking 3–5 days after stimulation and then slowly declining
(Figure 1a). We calculated the magnitude of telomerase activity over a
10‐day period following stimulation by measuring, for each study
group, the area under the curve (AUC) of Figure 1a,b. Telomerase activ-
ity in stimulated T cells from our pool of 21 centenarians was signifi-
cantly higher compared to 67‐ to 83‐year‐old individuals and was
comparable to that of 50‐ to 66‐year‐old individuals (Figure 1a,b).
In addition, the total number of T cells produced was greater for
centenarians compared with those 67–83 years old (Figure 1c). Since
telomerase is believed to increase the cellular replicative lifespan
through telomere maintenance, we investigated whether telomerase
activity correlated with the number of cell divisions. We found a signifi-
cant correlation between T‐cell telomerase activity at Day 3 of stimula-
tion (peak) and the maximal number of cells (a proxy for the rate of cell
division) over a 10‐day period (Figure 1d). This suggests that telomerase
activity in stimulated T cells may be a biomarker of the magnitude of
stimulation‐induced responses. The combined results show that in our
study population, stimulated T cells from centenarians express higher
levels of telomerase activity and proliferate better than T cells from
younger unrelated old individuals (67–83 years old).
2.2 | Some centenarians have global genome
expression profiles more similar to that of young
adults
To identify genes potentially associated with the centenarians’ T‐cell
phenotype, we compared in a subset of our study population the
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global gene expression profiles of stimulated T cells by RNA‐se-
quencing. Since most of the centenarians were females, we only ana-
lyzed women in order to avoid confounding factors that depend on
gender. In our initial exploratory RNA‐seq analysis, we investigated
whether in stimulated T cells, there existed characteristic expression
profiles defining young (23–39 years old), old (67–83 years old), and
centenarians. We used both principal component analysis (PCA) and
unsupervised hierarchical clustering (HCL) to visualize the data. In
both PCA and HCL, we noticed the same division among sample
(Figure 2a, Supporting Information Figure S1), and the three‐dimen-
sional representation (PCA) was chosen to illustrate this finding that
ultimately guided our subsequent DESeq2 analysis. As might be
expected, both young and old individuals exhibited very different
gene expression profiles (Figure 2a). Interestingly, the centenarian
group was heterogeneous, with some centenarians “Group 1” clus-
tering with the old and some centenarians “Group 2” clustering with
the young individuals (Figure 2a). When compared to young healthy
subjects, both old (67–83 years old) and centenarians Group 1 dis-
played more than 5,000 genes differentially expressed (5,778 and
5,382 genes, respectively, p ≤ 0.05) (Figure 2b,c). However, cente-
narians Group 2 had fewer genes differentially expressed (2,589
genes, p ≤ 0.05) and with less dramatic fold change differences (Fig-
ure 2d). Consistent with the PCA analysis, stimulated T cells from
Group 2 centenarians also had 2,197 genes whose expression level
was significantly different compared to Group 1 centenarians (Fig-
ure 2e).
After completing these initial transcriptomic analyses, we checked
the health status (medical records) and both cognitive and physical
performances, respectively, measured by using the Mini‐Mental State
Examination (MMSE) test and the Lawton Instrumental Activities of
Daily Living (IADL) test (Folstein, Folstein, & McHugh, 1975; Lawton
& Brody, 1969). Interestingly, Group 2 centenarians (that clustered
with the young healthy group) had significantly better cognitive and
physical performances and were also affected by a significantly lower
number of age‐related diseases compared with Group 1 centenarians
(that clustered with the old‐aged group) (Table 1). Together, we inter-
pret these results to suggest that combining all centenarians into one
group is likely to give heterogeneous results.
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F IGURE 1 Telomerase activity and proliferation capacity in stimulated peripheral blood mononuclear cell (PBMC). (a) Telomerase activity
measured by ddTRAP on stimulated PBMC at Days 0, 1, 3, 5, 7, and 10 after stimulation with anti‐CD3/anti‐CD28 Dynabeads. *p < 0.05 vs.
each of the other groups. ▲p < 0.05 vs. both 23–39 years old and 50–66 years old (b) Total telomerase activity (area under the curve, AUC)
over a 10‐day period of stimulation. *p < 0.05 vs. each of the other groups. **p < 0.05 vs. centenarians. (c) Total cell number after 10 days of
stimulation (for all samples, two million PBMCs were stimulated at day 0). *p < 0.05 vs. each of the other groups. (d) Correlation between
telomerase activity at Day 3 after stimulation and total cell number at Day 10
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2.3 | Healthier centenarians clustering with the
young also have significantly longer telomeres
compared to their centenarian peers
Telomere length is believed to be a marker of biological age and
exposure to various age‐related diseases (Epel et al., 2009; Shay,
2016). Since Group 2 centenarians were by far healthier than Group
1 centenarians (Table 1), we next investigated whether they also had
longer T‐cell telomeres. We measured both the average telomere
length and the length of the shortest 20% telomeres using a recently
developed highly sensitive assay (TeSLA, Telomere Shortest Length
Assay) (Lai et al., 2017).
Principal Component Analysis (PCA)
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F IGURE 2 Global gene expression profile comparisons between young, old (67–83 years old), and centenarians. (a) Principal component
analysis (PCA) representing young, old (67–83 years old), and the two subsets of centenarians (Group 1 and Group 2). (b–d) Volcano plots of
genes differentially expressed (p < 0.05) between young vs. old, and young vs. the two subsets of centenarians (Group 1 and Group 2). (e)
Volcano plots of genes differentially expressed (p < 0.05) between the two subsets of centenarians (Group 1 vs. Group 2)
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Interestingly, Group 2 centenarians had longer average telomere
length compared with Group 1 centenarians (3.49 ± 0.35 vs.
2.85 ± 0.24 kb, respectively, p = 0.025) (Supporting Information Fig-
ure S2). Moreover, Group 2 centenarians were also characterized by
a particularly low prevalence of critically short telomeres (length of
the shortest 20% telomeres: 1.86 ± 0.21 vs. 1.21 ± 0.14 kb in Group
2 vs. Group 1, respectively, p = 0.002) (Supporting Information Fig-
ure S2).
Since we observed a dramatic difference in overall health status
between Group 2 centenarians (healthier: disease count ≤3; MMSE
≥24; IADL ≥5) and Group 1 centenarians (frail: disease count ≥5;
MMSE ≤20; IADL ≤3) (Table 1), we divided the remaining 13 cente-
narians in our population based on these criteria and obtained four
additional healthier centenarians and four additional frail centenari-
ans. Out of the remaining five centenarians, either we did not have
enough DNA/RNA to run more experiments (three centenarians) or
we did not have sufficient detailed medical records (two centenari-
ans). We performed TeSLA on the additional eight centenarians (four
healthier and four more frail) and observed that the four healthier
centenarians had significantly longer telomeres compared to the four
frail centenarians (average telomere length: 3.08 ± 0.16 vs.
2.59 ± 0.15 kb, p = 0.004; Shortest 20% telomeres: 1.57 ± 0.21 vs.
1.18 ± 0.07 kb, p = 0.012).
Based on these results, we renamed the original Group 2
together with the additional four healthier centenarians as “high‐per-
forming” centenarians (HP Cent) since they are both healthier (dis-
ease count ≤3; MMSE ≥24; IADL ≥5) and have longer telomeres.
Accordingly, we renamed the original Group 1 together with the
additional four more frail centenarians as “low‐performing” centenari-
ans (LP Cent) since they are both more frail (disease count ≥5;
MMSE ≤20; IADL ≤3) and have shorter telomeres.
We matched the eight HP Cent and eight LP Cent with eight old
(75 ± 3 years old) and eight young (30 ± 2 years old). As might be
expected, with increasing age, we observed average telomere length
shortening as well as a higher prevalence of critically short telomeres
(Figure 3a,b). Again, taken together, HP Cent had longer telomeres
compared with the cohort of LP Cent (Figure 3a,b). Longer telomeres
can be due to inherited genetic factors, differences in life style (e.g.,
smoking habits, regular exercise and healthy diet), or reduced patho-
logical factors (e.g., less exposure to disease). We found no differ-
ences in life style habits between high‐ and low‐performing
centenarians (data not shown). However, T cells from HP Cent had a
significantly higher telomerase activity upon stimulation (Supporting
Information Figure S3a,b), suggesting that longer telomeres in
healthy centenarians’ T cells might be associated with a better ability
to up‐regulate telomerase following antigen presentation.
2.4 | Identification of genes potentially involved in
healthy aging and healthy T‐cell responses to
stimulation
Since HP Cent have relatively long telomeres, an excellent health
status based on their age and global gene expression profiles that
are more similar to that of young adults, we employed HP Cent as a
model to identify genes that might potentially be biomarkers of
healthy aging and optimal T‐cell responses to stimulation.
In order to select potential biomarker genes, we employed a ser-
ies of stringent criteria (Figure 4). Briefly, we first selected the genes
whose expression level was significantly (p < 0.05) different between
old (67–83 years old) and both young and HP Cent. The expression
level of the genes contained in this preliminary list significantly chan-
ged in one of the following ways: (a) age‐related increase (young <
old < HP Cent); (b) age‐related decrease (young > old > HP Cent);
(c) down‐regulation in both young and HP Cent (young and HP
Cent < old); (d) up‐regulation in both young and HP Cent (young
and HP Cent > old). Genes whose expression changed based on the
individual's age (1 and 2 above) are potentially involved in the aging
process but may not play a crucial role in promoting healthy aging
and extraordinary longevity. We therefore excluded such genes by
further selecting only the genes whose expression level was more
similar between young and HP Cent compared to the old individuals
(3 and 4 above) and with at least 0.5 log2 fold difference (Figure 4).
TABLE 1 Health status assessment of the individuals selected for global genome expression profile analysis by RNA‐sequencing. Disease
count was determined by evaluating the presence of the following diseases: Acute myocardial infarction, stroke, angina, hypertension, COPD,
dementia, depression, diabetes, thyroid dysfunction, arthrosis, chronic liver diseases, and chronic kidney diseases
Health status assessment
Centenarians group 1
(n = 4)
Centenarians group 2
(n = 4)
Old subjects
(n = 5)
Young subjects
(n = 5)
p
Value
Age, years, mean ± SD 103.8 ± 2.5 103.5 ± 3.1 75.0 ± 4.2a 24.5 ± 2.1a <0.001
Gender, female, % 100 100 100 100 NA
Smokers, % 0 0 0 0 NA
Body mass index (BMI), mean ± SD 22.7 ± 2.5 25.1 ± 3.0 26.0 ± 4.3 24.5 ± 5.3 0.720
Cognitive performance, MMSE score (0–30),
mean ± SD
14.2 ± 13.3a 28.0 ± 1.4 30.0 ± 0.0 30.0 ± 0.0 0.001
Physical performance, IADL score (0–8),
mean ± SD
1.8 ± 1.0a 6.8 ± 1.5 8.0 ± 0.0 8.0 ± 0.0 <0.001
Disease count per individual, mean ± SD 6.0 ± 0.8a 2.5 ± 0.6b 1.0 ± 0.7 0.0 ± 0.0 <0.001
ap < 0.05 vs. each of the other groups. bp < 0.05 vs. young subjects.
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While HP Cent are potentially characterized by expression profiles
that promote healthy aging and increased lifespan, it is uncertain
whether LP Cent also have a predisposition to longevity or they are
just “fortunate survivors.” For this reason, we did not employ addi-
tional criteria involving the LP Cent.
We finally obtained a list of 1,857 genes whose expression sig-
nificantly changed in old individuals (67–83 years old) compared with
the young subjects but did not change or only mildly changed in HP
Cent (Figure 4). Interestingly, 99.4% of these genes (1,846 out of
1,857) had a similar trend in LP Cent as compared to the old (if up‐
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F IGURE 3 Telomere length measurements by TeSLA (Telomere Shortest Length Assay) in young, old, high‐, and low‐performing
centenarians. (a) Average telomere length. (b) Length of the shortest 20% telomeres. *p < 0.05 vs. each of the other groups
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873 genes up-regulated (p < 0.05)
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2
F IGURE 4 Employed criteria to select genes potentially involved in healthy aging and heat map showing genes differentially expressed
between both young and high‐performing centenarians vs. old (67–83 years old) individuals
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regulated in both young and HP Cent, they were down‐regulated in
both old and LP Cent and vice versa) (Figure 4). Furthermore, 67%
of these genes (1,247 out of 1,857) were also differentially
expressed (p < 0.05) between high‐ vs. low‐performing centenarians
(data not shown). This strengthens the hypothesis that HP Cent
might potentially have a better ability to regulate the expression of
genes involved in healthy aging and “more youthful” T‐cell responses
to stimulation.
We employed this list of 1,857 selected genes to perform a gene
set enrichment analysis (GSEA). Genes up‐regulated in stimulated T
cells from both young and HP Cent compared to the old were part
of pathways involved in processes such as antigen processing and
presentation, responses to stimulus, and cellular defense responses
(Table 2). This is consistent with the better response to stimulation
observed in both young and HP Cent. One important gene within
such pathways is the co‐stimulatory receptor CD28, essential for
proper T‐cell stimulation. In order to further investigate whether the
improved response of T cells from HP Cent is due, at least in part,
to an increased expression of the co‐stimulatory receptor CD28, we
validated CD28 expression levels using droplet digital PCR (ddPCR).
For validation of gene expression, we employed the eight HP Cent,
eight LP Cent, eight old (75 ± 3 years old), and eight young
(30 ± 2 years old) previously selected by using the criteria illustrated
above. Interestingly, stimulated T cells from HP Cent exhibited sig-
nificantly higher expression of CD28 compared with stimulated T
cells from both old individuals and LP Cent (Figure 5a).
Gene set enrichment analysis of genes down‐regulated in stimu-
lated T cells from both young and HP Cent compared to the old
revealed enrichment of genes involved in cytokine‐mediated
signaling pathways, apoptosis, and inhibition of cell development
(Table 2). Gene set enrichment analysis on the 2,179 genes differen-
tially expressed between high‐ and low‐performing centenarians (Fig-
ure 2e) revealed most of these pathways were also enriched
(Supporting Information Table S1). Interestingly, both young and HP
Cent exhibited down‐regulation of pathways regulating apoptotic
signaling (Table 2, Supporting Information Table S1). These pathways
are particularly important since they contain apoptotic (e.g., BAX and
PD‐1) and inflammatory genes (e.g., TNF‐ɑ, IL‐1ɑ, IL‐1β, and NLRP3)
that have been previously reported as potential major drivers of
aging and age‐related diseases (Franceschi & Campisi, 2014; Ozaki,
Campbell, & Doyle, 2015). We validated the expression levels of
these genes by ddPCR.
Consistent with our RNA‐sequencing data, young and HP Cent T
cells had reduced expression of both BAX, a key protein involved in
p53‐mediated apoptosis (Reyna et al., 2017), and PD‐1, a cell death
inducer also involved in cancer and autoimmune diseases (Wang,
Sun, Wright, Wang, & Gu, 2016) (Figure 5b,c). Also, young and HP
Cent had reduced expression levels of pro‐inflammatory cytokines
and increased levels of the anti‐inflammatory cytokine IL‐10 (Fig-
ure 5d–h), suggesting that a lower grade of inflammation might pro-
tect HP Cent from age‐related disease onset and progression.
IGF‐1 is an additional important gene that is part of the path-
ways regulating extrinsic apoptotic signaling that emerged from the
GSEA analysis. IGF‐1 appears to be important for human longevity
and previous studies on centenarians showed that longevity was
associated with decreased plasma levels of IGF‐1 and preserved
insulin sensitivity (Salvioli et al., 2009). Even though IGF‐1 is mainly
produced by other tissues, we found that IGF‐1 expression was
TABLE 2 Biological pathways enriched in both young and high‐performing centenarians compared to the old (67–83 years old) by gene set
enrichment analysis
Name
NES
HP
Cent vs.
Old
FDR
q‐value
HP
Cent
vs. Old
NES
Young
vs. Old
FDR
q‐
value
Young
vs. Old
Up‐ (↑) or down
(↓)‐regulated in
both young and
HP Cent vs. Old
GO_ACTIVATION_OF_IMMUNE_RESPONSE 2.2888 0.0314 2.2068 0.0219 ↑
GO_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE 2.2859 0.0157 2.3343 0.0131 ↑
GO_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION 2.2643 0.0150 2.3787 0.0144 ↑
GO_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION −1.7202 0.0453 −1.9702 0.0334 ↓
GO_REGULATION_OF_CELLULAR_COMPONENT_MOVEMENT −1.9907 0.0490 −2.0423 0.0229 ↓
GO_TERPENOID_METABOLIC_PROCESS −2.0182 0.0411 −2.3142 0.0016 ↓
GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION −2.2221 0.0042 −2.4383 0.0010 ↓
GO_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY −2.0373 0.0376 −2.0192 0.0266 ↓
GO_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY −2.0931 0.0243 −1.8600 0.0426 ↓
GO_REGULATION_OF_ANATOMICAL_STRUCTURE_MORPHOGENESIS −2.0164 0.0385 −1.9537 0.0389 ↓
GO_TISSUE_DEVELOPMENT −2.0301 0.0378 −2.1060 0.0124 ↓
GO_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT −2.0671 0.0262 −2.2090 0.0047 ↓
GO_MULTICELLULAR_ORGANISM_METABOLIC_PROCESS −2.2696 0.0027 −2.3433 0.0011 ↓
GO_MULTICELLULAR_ORGANISMAL_MACROMOLECULE_METABOLIC_PROCESS −2.3252 0.0010 −2.4407 0.0021 ↓
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significantly down‐regulated in stimulated T cells from HP Cent but
not from LP Cent and old individuals (Figure 5i).
2.5 | Genome distribution of genes associated with
healthy aging
We next investigated the distribution of the 1,857 genes more simi-
larly expressed in the young and HP Cent cohorts compared with
both the old and LP Cent cohorts (Figure 4). We performed a posi-
tional gene enrichment (PGE) analysis for high‐resolution identifica-
tion of over‐represented chromosomal regions. The strength of such
an approach relies on a query optimization strategy (that allows one
to virtually consider all the possible chromosomal regions for enrich-
ment), and on the multiple testing correction (which discriminates
truly enriched regions vs. those that can occur by chance) (De Pre-
ter, Barriot, Speleman, Vandesompele, & Moreau, 2008). We
obtained a total of 264 significantly (p < 0.05) enriched loci
potentially associated with healthy aging (Supporting Information
Table S2). These loci were not randomly scattered among chromo-
somes, but mainly located on chromosomes 1, 2, 7, 12, and 17 (Sup-
porting Information Table S2).
We previously identified a group of genes whose expressions
were directly regulated by telomere length (telomere position effects
over long distances, TPE‐OLD) (Lou et al., 2009; Robin et al., 2014).
In these studies, the presence of long telomeres resulted in a telom-
ere “chromosome loop” approaching genes up to 10 Mb away of the
telomere end. In cells with short telomeres, these interstitial telom-
ere loops are lost and the same loci became separated as observed
by in situ co‐FISH analyses (Robin et al., 2014). Telomere looping
may promote epigenetic regulation of gene expression (it generally
silences gene expression). TPE‐OLD is therefore a mechanism by
which progressive telomere shortening directly leads to changes in
gene expression that, in turn, could contribute to aging and disease
initiation/progression long before telomeres become short enough to
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F IGURE 5 Gene expression levels measured by droplet digital PCR of candidate genes identified by RNA‐sequencing data analysis. Gene
expression was measured in T cells after a 72‐hr period of stimulation. A total of eight young, eight old (67–83 years old), eight HP Cent, and
eight LP Cent were analyzed. *p < 0.05 vs. both old and low‐performing centenarians; **p < 0.05 vs. all the other groups
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cause critical DNA damage responses and senescence (Robin et al.,
2014). Among the 264 significantly enriched loci (PGE analysis), we
investigated the distribution of the 63 regions located within 10 Mb
of the telomere ends. These 63 regions (containing genes differen-
tially expressed in both HP Cent and young compared with both old
and LP Cent) were not randomly scattered but were mostly located
on chromosomes 12p, 14q, 17q, 19q, and 19p (Supporting Informa-
tion Table S3, Figure S4). Interestingly, the exact same chromosome
ends were previously reported to be potentially associated with
TPE‐OLD (Robin et al., 2014). Furthermore, a recent genomewide
linkage analysis on the DNA sequence of 2,118 nonagenarian Cau-
casian sibling pairs reported the same chromosome arms (except for
chromosome 12p) are associated with longevity (Beekman et al.,
2013). Since HP Cent had a very low prevalence of critically short
telomeres as opposed to LP Cent (Figure 3a,b, Supporting Informa-
tion Figure S2), TPE‐OLD may potentially be one of the mechanisms
underlying the peculiar gene expression profiles of HP Cent.
3 | DISCUSSION
Even with the current technology and progress in science and medi-
cine, the probability to live beyond 100 years of age is still extremely
rare as the prevalence of centenarians in the United States and Eur-
ope is ~22 and 17 centenarians per 100,000 inhabitants, respectively
(https://www.pewresearch.org/fact-tank/2016/04/21/worlds-cente
narian-population-projected-to-grow-eightfold-by-2050/) (Teixeira,
Araujo, Jopp, & Ribeiro, 2017). Furthermore, the probability to live
healthily past the age of 100 years is even lower as more than 70%
of centenarians are affected by age‐related diseases (Andersen,
Sebastiani, Dworkis, Feldman, & Perls, 2012). Some exceptionally
long‐lived individuals, the so‐called escapers, can, however, live a
mostly disease‐free life for over a century (Andersen et al., 2012),
indicating that being “lucky” and/or having a healthy lifestyle is not
sufficient and more complicated genetic, epigenetic, and biological
mechanisms must take place in order to simultaneously promote
healthy aging and extreme longevity.
Nonetheless, these mechanisms are still poorly understood.
While there have been previous studies examining exceptionally
human longevity, such as in centenarians (Beekman et al., 2013;
Franceschi & Bonafe, 2003; Sebastiani & Perls, 2012), almost all of
these have been performed using resting PBMC and with samples
from heterogeneous populations combining both frail/low‐performing
and healthy/high‐performing centenarians. Rather than stratifying
individuals simply by chronological age, they may more appropriately
be grouped by how well they are aging (biological aging) by evaluat-
ing medical records and multiple indicators of health such as BMI,
blood pressure, blood glucose, hematocrit, cholesterol, and perhaps
most important physical and cognitive functions, together with exist-
ing candidate biomarkers under more physiological conditions.
Peripheral blood mononuclear cells, and in particular T cells, act
as peripheral biomarkers that mirror alterations within a multitude of
organs and tissues (Arosio et al., 2014) and therefore are a useful
cell model to study human aging. However, these cells require
antigen activation in order to trigger proper defense responses, and
once activated undergo dramatic changes in both gene expression
and proliferation rate. Our goal was to partially recapitulate in vitro
active physiological immune responses and compare them between
high‐performing centenarians (“escapers”), low‐performing centenari-
ans (“survivors”), and younger study groups.
Here, we describe how centenarians’ immune cells respond to
anti‐CD3/anti‐CD28‐induced stimulation and present global gene
expression profiles of centenarian‐stimulated immune cells. Cur-
rently, there is still debate whether the age‐associated telomere
attrition of immune cells is also coordinated by changes in telom-
erase activity (Lin et al., 2015), or if the capacity for telomerase
expression in human lymphocytes is unaltered with age (Son, Mur-
ray, Yanovski, Hodes, & Weng, 2000). Our findings show that upon
T‐cell stimulation, telomerase activity decreases with age except for
HP Cent who have a more robust telomerase activity up‐regulation
that also correlated with increased telomere length and proliferation
capacity (Figure 1a–d and 3a,b).
Previous centenarian studies (Beekman et al., 2013; Franceschi &
Bonafe, 2003; Sebastiani & Perls, 2012) did not indicate variations in
absolute numbers of lymphocytes, and in the present study, we
found similar results (lymphocytes × 103/mm3 in blood from HP
cent, LP cent, and old were 1.67 ± 0.57, 1.78 ± 0.49, and
1.65 ± 0.50, respectively, p = 0.836), suggesting that the difference
in stimulation‐induced responses between high‐ and low‐performing
centenarians is likely due to specific immune cell characteristics
rather than their absolute number in the blood. However, the distri-
bution of various T‐cell subsets (e.g., CD4+/CD28+, CD4+/CD28−,
CD8+/CD28+, CD8+/CD28−) could be different. CD28 gradual loss is
one of the most profound and consistent events contributing to the
age‐associated changes in T cells in humans (Fagnoni et al., 1996).
Early studies showed that the loss of CD28 was associated with
decreased anti‐CD3 stimulation and decreased ability to up‐regulate
telomerase after activation (Huang et al., 2017; Valenzuela & Effros,
2002). In addition, the shorter telomeres in CD28− compared to
CD28+ T cells (Monteiro, Batliwalla, Ostrer, & Gregersen, 1996) may
be due to the observation that CD28 signaling is required for opti-
mal telomerase induction (Huang et al., 2017). It is therefore possible
that HP Cent might retain more CD28+ cells, leading in turn to a
more robust response to the anti‐CD3/anti‐CD28‐induced stimula-
tion and a to more “youthful” global gene expression profile.
Gaining a better understanding of immune cell responses associ-
ated with human healthy aging and overall healthspan has important
translational implications. To further investigate this topic, we first
compared in a subset of our study population global gene expression
profiles of stimulated T cells. We observed that some “high‐perform-
ing” centenarians were more similar to the young adults than to both
the old and the other “low‐performing” centenarians in terms of glo-
bal gene expression profiles (PCA analysis and Volcano plots) (Fig-
ure 2a–e). With the aim to identify genes potentially associated with
the high‐performing centenarians’ phenotype, we employed stringent
criteria and obtained a selected list of differentially expressed genes
(Figure 4). Gene ontology analysis of this gene list (and validation by
TEDONE ET AL. | 9 of 13
ddPCR of the expression level of selected candidate genes) revealed
that both high‐performing centenarians and the young cohort had
up‐regulated pathways also involved in the activation of immune
responses and down‐regulated pathways also involved in apoptosis
and inflammation (Table 2, Supporting Information Table S1, Fig-
ure 5). Decreased expression of pro‐apoptotic factors such as BAX
and PD‐1 in HP Cent (Figure 5b,c) could promote lower cellular turn-
over leading, in turn, to decreased telomere shortening and mainte-
nance of the cell replicative potential.
Epidemiological evidence shows that a state of chronic low‐grade
inflammation correlates with many aging‐associated phenotypes (e.g.,
changes in body composition, energy production/utilization, and
immune senescence) and represents a highly significant risk factor
for both increased morbidity and mortality (Franceschi & Campisi,
2014). In fact, pro‐inflammatory genes as TNF‐ɑ, IL‐1ɑ, IL‐1β, and
NLRP3 are associated with a wide range of age‐related disorders,
including cardiovascular, neurodegenerative, and metabolic diseases
(Anders, 2016; Croft et al., 2012; Ozaki et al., 2015) and the level of
soluble TNF‐ɑ R1 was identified as a predictor of 10‐year all‐causes
of mortality (Varadhan et al., 2014). It is therefore consistent that
the healthiest centenarians in our study population displayed
reduced expression of inflammatory cytokines (Figure 5d–g).
Inflammation does not always lead to tissue degeneration since
it is also part of normal tissue remodeling. One factor that can dis-
criminate between adaptive and pathogenic inflammation is the rela-
tive strength of anti‐inflammatory responses. Anti‐inflammatory
responses not only compensate acute inflammation events but can
also partially counteract chronic inflammatory processes (Franceschi
et al., 2007). Compared to both LP Cent and the 67‐ to 83‐year‐old
cohort, HP Cent also had increased expression of IL‐10, one of the
most effective anti‐inflammatory cytokines that protects tissue integ-
rity and attenuates disease severity (Ouyang, Rutz, Crellin, Valdez, &
Hymowitz, 2011) (Figure 5h). This suggests that in some exceptional
individuals, such as HP Cent, chronic inflammation may develop
more slowly or may be restricted or balanced by anti‐inflammatory
responses that are less prominent in the general population.
When studying complex multifactorial processes such as longev-
ity and healthy aging, it is of great importance to generate gene lists
differentially expressed in the sample subgroups under investigation
and to delineate chromosomal regions that are significantly enriched
in those genes. Our positional gene enrichment analysis revealed
several over‐represented chromosome regions (Supporting Informa-
tion Tables S2 and S3). Interestingly, only when we investigated the
distribution of the enriched regions within 10 Mb of the telomere
ends did we obtain results that were comparable to previous studies
based on large cohorts of long‐lived individuals (Beekman et al.,
2013; Brooks‐Wilson, 2013).
We have previously documented that some human genes can be
regulated by the length of telomeres over long distances (TPE‐OLD)
(Lou et al., 2009; Robin et al., 2014). Long telomeres promote the
formation of a chromatin loop at a distance of up to several mega-
bases from the chromosome end, influencing gene expression over
large distances (Lou et al., 2009; Robin et al., 2014). This novel
telomere looping mechanism implies that progressive telomere short-
ening can influence cell physiology and diseases associated with
aging long before telomeres become terminally short and inducing a
DNA damage signal. We speculate that a more efficient regulation
of telomerase activity in high‐performing centenarians’ T cells may
be responsible for improved telomere length maintenance mecha-
nisms, leading, in turn, to a differential expression (through TPE‐
OLD) of key genes that affect human physiology, aging, diseases,
and lifespan. Alternatively, this could be due to the genetic inheri-
tance of longer telomeres or to reduced turnover of hematopoietic
stem cells for a variety of reasons. It is also possible that higher
inflammaging processes in the old and LP Cent lead to an increased
rate of telomere shortening and, in turn, to TPE‐OLD‐dependent
changes in gene expression. Finally, TPE‐OLD in long‐lived humans
could be chromosome specific; thus, future correlations about single
telomere end lengths and gene expression profiles are necessary to
further explore this hypothesis.
The focus of our pilot study was to form the basis for the identi-
fication of valid and reliable biomarkers associated with mechanisms
that regulate healthy human immune cell aging. Our overarching
hypothesis is that there are specific candidate genes whose expres-
sion greatly differs in activated T cells from HP Cent when com-
pared to those from LP Cent. After further validation in larger study
populations, the biomarkers that we have identified may in the
future provide personalized geriatric medicine facilitating early diag-
nosis, prevention, and treatment of age‐related diseases to promote
healthy aging. Future studies on centenarians, in particular longitudi-
nal comparisons of immune cell responses over the transition from
healthy to unhealthy centenarians’ phenotype, are required to better
define the gene expression “signature” of healthy aging.
4 | MATERIAL AND METHODS
4.1 | Study design and participants
We performed a cross‐sectional study with PBMCs and T lympho-
cytes isolated from PBMCs of 114 Caucasian individuals under an
Institutional Review Board (IRB)‐approved protocol (certification
number STU 042014‐016). Briefly, we recruited 21 centenarians
(100+ years old) and 93 individuals aged 23–83 years.
The participant's age at time of enrollment was defined by birth
certificates stated by local registry offices and/or dates of birth as
stated on passports or identity documents. A trained multidisci-
plinary staff collected from the enrolled volunteer's information
regarding health status, currently used drugs, clinical history, and life-
style (smoking habits and alcohol consumption). Moreover, past and
current disease history was retrieved by an accurate evaluation of
the participants' clinical documentations. We were unable to obtain
CMV status on the centenarian cohort.
Subjects affected by cancer, infections or autoimmune diseases,
or on immunosuppressive treatment at the time of enrollment were
excluded from the study. Venous blood samples were drawn from
the participants under fasting conditions at the same time in the
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morning. The study protocol was approved by the Ethical Committee
of Saint’Orsola—Malpighi University Hospital (Bologna, Italy), and
written informed consent was obtained from all subjects in accor-
dance with the International Declaration of Helsinki.
4.2 | Peripheral blood mononuclear cell isolation
and stimulation
Peripheral blood mononuclear cells were isolated from peripheral
blood by centrifugation with Ficoll‐Paque Plus (GE Healthcare) and
were then cryopreserved at −140°C pending analysis. Cells were
thawed 24 hr prior to mitogen stimulation and cultured in RPMI+-
GlutaMAX‐I with 10% fetal bovine serum, 1% penicillin, strepto-
mycin, and amphotericin B. After 24 hr, the cell suspensions were
transferred into a new flask to remove the monocytes (that adhered
to the flask's plastic). Peripheral blood mononuclear cells were stimu-
lated by adding Dynabeads Human T‐Activator CD3/CD28 (Life
Technologies) in a 1:1 ratio. After 72 hr of stimulation, Dynabeads
were removed using a magnet and cells were cultured for a total of
10 days after stimulation. The percentage of live cells was deter-
mined every day by trypan blue exclusion using a TC20 Automated
Cell Counter (Bio‐Rad). The cell density was adjusted daily, and when
it exceeded 1.5 × 106/ml, cells were diluted with fresh complete
RPMI medium to a density of 1.0 × 106/ml.
4.3 | Telomerase enzymatic activity assay
Telomerase activity was assessed using the droplet digital TRAP
(ddTRAP) assay as previously described (Ludlow et al., 2014). Briefly,
cells were cultured and counted and 105 cells from each sample
were pelleted and stored at −80°C pending analysis. On the day of
the experiment, cell pellets were lysed on ice for 45 min with 40 µl
of NP‐40 Buffer (10 mM Tris–HCl, pH 8.0, 1 mM MgCl2, 1 mM
EDTA, 1% (vol/vol) NP‐ 40, 0.25 mM sodium deoxycholate, 10%
(vol/vol) glycerol, 150 mM NaCl, 5 mM β‐mercaptoethanol, 0.1 mM
AEBSF (4‐(2‐aminoethyl)benzenesulfonyl fluoride hydrochloride)).
Two microliters of cell lysate (5 × 103 cell equivalents) were added
to a 50 µl extension reaction containing 1× TRAP reaction buffer
(10× concentration: 200 mM Tris–HCl, pH 8.3, 15 mM MgCl2),
0.4 mg/ml BSA, 200 nM TS telomerase extension substrate (HPLC
purified, 5′‐AATCCGTCGAGCAGAGTT‐3′), and dNTPs (2.5 mM
each), incubated for 45 min at 25°C followed by telomerase inactiva-
tion at 95°C for 5 min, and then cooled at 4°C.
The ddPCR reaction contained 2 µl of extension products (200
cell equivalents), 1× EvaGreen ddPCR Supermix v2.0 (Bio‐Rad),
50 nM TS primer, 50 nM ACX primer (5′‐GCGCGGCTTACCCT-
TACCCTTACCCTAACC‐3′) (Ludlow et al., 2014) and dH2O to a
20 µl final volume per sample. Droplets were generated exactly as
reported (Ludlow et al., 2014) and transferred to a 96‐well PCR plate
(twin‐tec 96‐well plate, Eppendorf, Fisher) then sealed with foil
(Thermo Scientific, AB0757). PCR was performed in a T100 thermo-
cycler (Bio‐Rad) with a ramp rate of 2.5°C/s between all steps. Acti-
vation of Taq polymerase (95°C for 5 min) was followed by 40
cycles of 95°C for 30 s, 54°C for 30 s, and 72°C for 30 s and then
cooled at 12°C.
After PCR, the fluorescence was read on a QX200 droplet reader
(Bio‐Rad) as previously described (Ludlow et al., 2014). Telomerase
activity values were corrected by subtracting background fluores-
cence (negative control) and normalized, sample by sample, based on
the percentage of live cells in culture when the cell pellets were col-
lected. Telomerase activity was expressed as the number of telom-
erase‐extended TS molecules per cell equivalent (telomerase
products per cell).
4.4 | Shortest telomere length measurement
Genomic DNA was extracted using the Gentra Puregene DNA
extraction kit (Qiagen) according to the manufacturer's instructions.
Each DNA sample was quantified on a NanoDrop (Thermo Scientific)
for concentration and purity, and integrity of DNA was determined
as previously indicated (Lai et al., 2017).
The TeSLA method was performed exactly as described (Lai
et al., 2017). Briefly, 50 ng of genomic DNA was added to a final
volume of 20 µl of ligation buffer containing 1,000 units of T4 DNA
ligase (New England Biolabs), 1× Cut Smart Buffer (New England
Biolabs), 1 mM ATP, and 1 nM of TeSLA telorettes (TeSLA Telo 1–6)
(Lai et al., 2017) and incubated at 35°C for 16 hr followed by heat
inactivation at 65°C for 10 min. After ligation, genomic DNA was
digested using a set of restriction enzymes (2 units each of CviAII,
BfaI, NdeI, and MseI, New England Biolabs) as reported (Lai et al.,
2017) and then treated with 1 unit of shrimp alkaline phosphatase
(rSAP; New England Biolabs) at 37°C for 60 min in a final volume of
50 µl. This mixture was subsequently heat inactivated at 80°C for
20 min, and 10 µl of sample was added to 10 µl of adapter ligation
mix (1 μM AT adapter, 1 μM TA adapter, 1 mM ATP, 1× Cut Smart
Buffer, and 2,000 units of T4 DNA Ligase) and incubated at 16°C
for 16 hr. After adapter ligation, the sample was heat inactivated at
65°C for 10 min and subsequently diluted to a concentration of
15 pg DNA/µl (1:25 dilution). For each sample analyzed, we per-
formed eight independent PCRs (94°C for 2 min followed by 26
cycles of 94°C for 15 s, 60°C for 30 s, and 72°C for 15 min) using a
total of 25 µl mix containing 30 pg DNA, 2.5 units of FailSafe
enzyme (Epicenter), 1× FailSafe buffer H (Epicenter), and 250 nM
primers (adapter and TeSLA TP) (Lai et al., 2017). PCR products were
run on a 0.85% agarose gel (1.5 V/cm for 19 hr) followed by South-
ern blot analysis to detect amplified telomeres as previously
described (Lai et al., 2017). Southern blot images were finally ana-
lyzed by using MATLAB‐based software to automatically and accu-
rately detect and size annotate the telomere bands including the
percentage of shortest telomeres and average telomere length.
4.5 | RNA sequencing and data analysis
RNA was extracted using Qiagen's RNeasy plus mini kit following
manufacturer's protocol and sequenced at the UT Southwestern
Genomics Sequencing Core on Illumina HiSeq 2500, 2 × 100 bp
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configuration. Trimmomatic version 0.32 (Bolger, Lohse, & Usadel,
2014) was used to remove poor quality reads and adapter
sequences, with FASTQC performed before and after trimming. Raw
counts were obtained using HTSeq (Anders, Pyl, & Huber, 2015) on
BAM files generated by aligning trimmed PE fastq files to UCSC
human genome version hg19 using tophat 2.0.12 (Trapnell et al.,
2010). Normalized counts, generated using DESeq2 (Love, Huber, &
Anders, 2014), were used for initial exploratory analysis. Unsuper-
vised clustering and principal component analysis (performed using
R, version 3.4.1) were used to visualize the behavior of samples
using all genes in which the normalized count was >0 in all samples.
Differential gene expression analysis between young and old, young
and LP Cent, young and HP Cent, HP Cent and LP Cent, and old
and HP Cent was performed using DESeq2 with Benjamini–Hoch-
berg‐adjusted p‐value <0.05 as cutoff for significance. Gene set
enrichment analysis was performed using default parameters (Subra-
manian et al., 2005) on log fold change ranked lists of the 1,857
genes identified by employing the criteria shown in Figure 4, and the
DESeq2 list of 2,197 genes differentially expressed between HP and
LP Cent. Positional gene enrichment (PGE) was performed on the
1,857 gene list (Figure 4) using the PERL script provided by De Pre-
ter et al. (2008). Raw data have been deposited on the Sequence
Read Archive (SRA) under accession SRP131755.
4.6 | Statistical analysis
Statistical analysis was performed using the software GraphPad
Prism 7.0. Telomerase activity, telomere length, cell proliferation
rate, and gene expression by ddPCR were compared between the
study groups by univariate ANOVA, followed by Bonferroni's correc-
tion. Correlations were performed by linear regression analysis.
p < 0.05 was used as the threshold value for statistical significance.
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